ReNeuron Group (LSE:RENE) Buildings And Improvements : £0.23 Mil (As of Sep. 2023)

View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group Buildings And Improvements?

ReNeuron Group's quarterly buildings and improvements declined from Sep. 2022 (£0.33 Mil) to Mar. 2023 (£0.28 Mil) and declined from Mar. 2023 (£0.28 Mil) to Sep. 2023 (£0.23 Mil).

ReNeuron Group's annual buildings and improvements increased from Mar. 2021 (£0.00 Mil) to Mar. 2022 (£0.37 Mil) but then declined from Mar. 2022 (£0.37 Mil) to Mar. 2023 (£0.28 Mil).

ReNeuron Group Buildings And Improvements Historical Data

The historical data trend for ReNeuron Group's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Buildings And Improvements Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Buildings And Improvements

Get a 7-Day Free Trial

0.66

0.37

0.28

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Buildings And Improvements	Get a 7-Day Free Trial															-	0.37	0.33	0.28	0.23

ReNeuron Group Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

ReNeuron Group (LSE:RENE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

RNUGF:USA RENE.GB:UK RQE1:Germany

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.